- epidermal growth factor receptor phosphatidylinositol 3,4,5 trisphosphate 3
phosphatase protein p53 retinoblastoma protein uvomorulin analytic method article cancer cell culture cancer genetics controlled study DNA microarray exon gene expression gene identification genetic algorithm genetic analysis genetic screening genetic transcription genetic variability human human cell human cell culture mutational analysis nucleotide sequence pattern based correlation sequence analysis single nucleotide polymorphism structure analysis wild type breast tumor cell transformation female gene expression profiling genetics population genetics tumor cell line tumor gene
- Nagel, J.H.A. Duijm, E. Vuerhard, M.J. Schutte, M. Wasielewski, M. Hollestelle, A. Elstrodt, F. Spek, P.J. van der Sillevis Smitt, P.A.E. French, P.J. Bralten, L.B.C. Peeters, J.K.
- Background: Identification of genes that are
causally implicated in oncogenesis is a major goal in cancer
research. An estimated 10-20% of cancer-related gene mutations
result in skipping of one or more exons in the encoded transcripts.
Here we report on a strategy to screen in a global fashion for such
exon-skipping events using PAttern based Correlation (PAC). The PAC
algorithm has been used previously to identify differentially
expressed splice variants between two predefined subgroups. As
genetic changes in cancer are sample specific, we tested the
ability of PAC to identify aberrantly expressed exons in single
samples. Principal Findings: As a proof-of-principle, we tested the
PAC strategy on human cancer samples of which the complete coding
sequence of eight cancer genes had been screened for mutations. PAC
detected all seven exon-skipping mutants among 12 cancer cell
lines. PAC also identified exon-skipping mutants in clinical cancer
specimens although detection was compromised due to heterogeneous
(wild-type) transcript expression. PAC reduced the number candidate
genes/exons for subsequent mutational analysis by two to three
orders of magnitude and had a substantial true positive rate.
Importantly, of 112 randomly selected outlier exons, sequence
analysis identified two novel exon skipping events, two novel base
changes and 21 previously reported base changes (SNPs).
Conclusions: The ability of PAC to enrich for mutated transcripts
and to identify known and novel genetic changes confirms its
suitability as a strategy to identify candidate cancer
- PLoS ONE, Volume 3, Issue 8, 20 August 2008, Article
- Instructions in case access is denied
Site powered by: